Hbk Investments L P Heron Therapeutics, Inc. Transaction History

Hbk Investments L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $526,706 - $837,942	-19,951 Reduced 61.67%	12,400 $482,000
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $48,821 - $76,291	-2,649 Reduced 7.57%	32,351 $893,000
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $518,000 - $659,750	35,000	35,000 $634,000

176

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $210M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.